df
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th df df df df df df
edition Woo Robinson Test Bank df df df df df
Chapter 1. The Role of the Nurse Practitioner as PrescriberMultiple Choice
df df df df df df df df df df
Identify the choice that best completes the statement or answers the question.
df df df df df df df df df df df
1. Nurse practitioner prescriptive authority is regulated by:
df df df df df df df
1. The National Council of State Boards of Nursing
df df df df df df df
2. The U.S. Drug Enforcement Administrationdf df df df
3. The State Board of Nursing for each state
df df df df df df df
4. The State Board of Pharmacy df df df df
2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN)
df df df df df df df df df df df df df
prescriber include:
df df
1. Nurses know more about Pharmacology than other prescribers because they take
df df df df df df df df df df
it both in their basic nursing program and in their APRN program.
df df df df df df df df df df df df
2. Nurses care for the patient from a holistic approach and include the patient
df df df df df df df df df df df df
in decision making regarding their care.
df df df df df df
3. APRNs are less likely to prescribe narcotics and other controlled substances.
df df df df df df df df df df
4. APRNs are able to prescribe independently in all states, whereas a
df df df df df df df df df df
physician’s assistant needs to have a physician supervising their practice.
df df df df df df df df df df
3. Clinical judgment in prescribing includes:
df df df df df
1. Factoring in the cost to the patient of the medication prescribed df df df df df df df df df df
2. Always prescribing the newest medication available for the disease process
df df df df df df df df df
3. Handing out drug samples to poor patients df df df df df df
4. Prescribing all generic medications to cut costs df df df df df df
4. Criteria for choosing an effective drug for a disorder include:
df df df df df df df df df df
1. Asking the patient what drug they think would work best for them
df df df df df df df df df df df
2. Consulting nationally recognized guidelines for disease management df df df df df df
3. Prescribing medications that are available as samples before writing a prescription
df df df df df df df df df df
4. Following U.S. Drug Enforcement Administration guidelines for prescribing df df df df df df df
5. Nurse practitioner practice may thrive under health-care reform because of:
df df df df df df df df df df
1. The demonstrated ability of nurse practitioners to control costs and improve
df df df df df df df df df df
patient outcomes df df
2. The fact that nurse practitioners will be able to practice independently
df df df df df df df df df df
3. The fact that nurse practitioners will have full reimbursement under
df df df df df df df df df
health- care reformdf df df
4. The ability to shift accountability for Medicaid to the state level
df df df df df df df df df df
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
df df df df df df
edition Woo Robinson Test Bank df df df df df
Chapter 1. The Role of the Nurse Practitioner as Prescriber
df df df df df df df df df
Answer Section
df df
MULTIPLE CHOICE df
1. ANS: d f d f 3 PTS: d f 1
2. ANS: d f d f 2 PTS: d f 1
3. ANS: d f d f 1 PTS: d f 1
4. ANS: d f d f 2 PTS: d f 1
5. ANS: d f d f 1 PTS: d f 1
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th df df df df df df
edition Woo Robinson Test Bank df df df df df
Chapter 2. Review of the Basic Principles of Pharmacology
df df df df df df df df
df Multiple Choice df
Identify the choice that best completes the statement or answers the question.
df df df df df df df df df df df
1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical
df df df df df df df df df df df df
to prescribing because:
df df df
1. Distribution of drugs to target tissue may be affected. df df df df df df df df
2. The solubility of the drug will not match the site of absorption.
df df df df df df df df df df df
3. There will be less free drug available to generate an effect. df df df df df df df df df df
4. Drugs bound to albumin are readily excreted by the kidneys. df df df df df df df df df
2. Drugs that have a significant first-pass effect:
df df df df df df df
1. Must be given by the enteral (oral) route only df df df df df df df df
2. Bypass the hepatic circulation df df df
3. Are rapidly metabolized by the liver and may have little if any desired action
df df df df df df df df df df df df df
4. Are converted by the liver to more active and fat-soluble forms
df df df df df df df df df df
3. The route of excretion of a volatile drug will likely be the:
df df df df df df df df df df df df df
1. Kidneys
2. Lungs
3. Bile and feces df df
4. Skin
4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a
df df df df df df df df df df
storage reservoir of the drug. Storage reservoirs:
df df df df df df df
1. Assure that the drug will reach its intended target tissue df df df df df df df df df
2. Are the reason for giving loading doses df df df df df df
3. Increase the length of time a drug is available and active df df df df df df df df df df
4. Are most common in collagen tissues df df df df df
5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
df df df df df df df df df df df df df df df
1. Propensity to go to the target receptor df df df df df df
2. Biological half-life df
3. Pharmacodynamics
4. Safety and side effects df df df
6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of
df df df df df df df df df df df df df df df df df
the prescription. This is considered a loading dose. A loading dose:
df df df df df df df df df df df
1. Rapidly achieves drug levels in the therapeutic range df df df df df df df
2. Requires four- to five-half-lives to attain df df df df df
3. Is influenced by renal function df df df df
4. Is directly related to the drug circulating to the target tissues
df df df df df df df df df df
7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic
df df df df df df df df df df df df df df df df df
effect is the:
df df df
1. Minimum adverse effect level df df df
2. Peak of action df df